Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report
A cartoon illustration of pie, bar and other graphs

What you need to know about Johnson & Johnson’s 2021 fourth-quarter and full-year earnings report

Check out this infographic breakdown of the company’s fourth-quarter and annual performance, with highlights from its Consumer Health, Pharmaceutical and Medical Devices businesses.

fourth-quarter-and-full-year-earnings-banner-0122.png

Today, Johnson & Johnson shared its 2021 fourth-quarter and full-year earnings report.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 136,000 employees across the globe working every day to help change the trajectory of health for humanity.

“Johnson & Johnson’s strong 2021 fourth-quarter and full-year results were driven by the relentless agility, resilience and commitment of our global colleagues,” says Joe Wolk, Executive Vice President and Chief Financial Officer, Johnson & Johnson. “We are well-positioned for the year ahead with a continued focus on optimizing our core businesses and investing in a robust pipeline of breakthrough innovations across the enterprise.”

For more details about the company’s 2021 fourth-quarter and full-year results, and to read a message from Chief Executive Officer Joaquin Duato, here’s an infographic highlighting key stats.


Johnson & Johnson EOY Q4 2021 Earnings infographic

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

This scientist couldn’t save his father from lung cancer—but the targeted treatments Robert Zhao, Ph.D., has since developed have helped countless others

Learn more about Zhao, his partnership with Johnson & Johnson and antibody-drug conjugates—a new type of cancer therapy that targets and kills cancer cells without harming healthy cells.

After their husbands were diagnosed with multiple myeloma, these 3 care partners became health equity activists

Kimberly Alexander, Michelle Ware-Ivy and Marsha Calloway-Campbell learned firsthand that Black individuals develop multiple myeloma at higher rates. That’s why they joined Johnson & Johnson’s That’s My Word® health equity campaign, which builds awareness about the disparities surrounding this rare blood cancer.

How Johnson & Johnson is working to get medications to people around the world who need them most

In the just-released 2024 Access to Medicine Index, the company ranks among the top 5 improving access to medicines.